Global Synthetic Biosensors Market Size By Type (Sensor Patch, Embedded Device), By Product (Wearable Synthetic Biosensors, Non-wearable Synthetic Biosensors), By Technology (Electrochemical Synthetic Biosensors, Optical Synthetic Biosensors), By Application (Point of Care (POC), Home Diagnostics), By Geographic Scope And Forecast
Published on: 2024-08-13 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Synthetic Biosensors Market Size By Type (Sensor Patch, Embedded Device), By Product (Wearable Synthetic Biosensors, Non-wearable Synthetic Biosensors), By Technology (Electrochemical Synthetic Biosensors, Optical Synthetic Biosensors), By Application (Point of Care (POC), Home Diagnostics), By Geographic Scope And Forecast
Synthetic Biosensors Market Size And Forecast
Synthetic Biosensors Market size was valued at USD 25.80 Billion in 2022 and is projected to reach USD 48.11 Billion by 2030, growing at a CAGR of 8.10% from 2023 to 2030.
The growing use of synthetic biosensors in industries such as pharmaceuticals, healthcare, food, agriculture, and the environment, among others, is expected to boost the worldwide market for synthetic biosensors. The growth in government expenditure on the health and pharmaceutical sectors, the incidence of heart disease and diabetes, and the trend toward self-monitoring are the major reasons that will drive the worldwide market for synthetic biosensors over the projected period. The Global Synthetic Biosensors Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Synthetic Biosensors Market Definition
Synthetic biology has enormous promise for delivering answers to problems in several areas of human life. Previously, synthetic biology-based bioenergy and bioremediation solutions were the primary foci of attention; however, biomedicine tactics are now being implemented. Aside from pharmaceuticals, synthetic biology is being investigated for the development of biosensors for diagnostics. The development of biosensing systems relies heavily on synthetic biology based on engineering principles.
Biosensors based on synthetic biology are bacterial systems that identify and eventually kill harmful microorganisms via quorum sensing. A synthetic biosensor’s ultimate purpose is to function as a therapeutic sensor-effector device that integrates diagnostic input with therapeutic output, providing all-in-one diagnostic and therapeutic solutions for future gene- and cell-based treatments.
Global Synthetic Biosensors Market Overview
The Global Synthetic Biosensors Market is expected to expand due to a rise in applications in industries such as pharmaceutical, healthcare, food, agriculture, environment, and others. During the projected period, the important drivers driving the Global Synthetic Biosensors Market are an increase in government expenditure in the health and pharmaceutical sectors, a growth in the prevalence of cardiovascular illnesses and diabetes, and an increasing trend of self-monitoring.
The key industry players in the global Synthetic Biosensors Market are concentrating on the development of low-cost biosensor devices for precise measurements. Furthermore, market players have enormous potential prospects due to the expanding uses of synthetic biosensors in the midst of the worldwide pandemic. During the projected period, technological improvements in synthetic biosensors and breakthroughs in the field of nanotechnology will drive the growth of the worldwide Synthetic Biosensors Market. In recent years, the development of synthetic biosensors has expanded; advancements in diagnostic accuracy, detection limits, quicker reactions, and downsizing for enhanced medical services have yet to be shown in clinical settings.
Global Synthetic Biosensors MarketSegmentation Analysis
The Global Synthetic Biosensors Market is segmented on the basis of Type, Product, Technology, Application, and Geography.
Synthetic Biosensors Market, By Type
- Sensor Patch
- Embedded Device
- Others
Based on Type, the market is segmented into Sensor Patch, Embedded Device, and Others. In 2021, the embedded device segment dominated the market accounting for the largest market share and it is expected to continue to do so over the next few years. These devices are utilized in a variety of settings, including home diagnostics, point-of-care (POC) diagnostics, research labs, the food and beverage sector, bioremediation, and environmental monitoring, As the Internet of Things (IoT) devices have grown in popularity, there has been a significant shift in how linked healthcare apps operate.
The Internet of Things (IoT) enables real-time monitoring, tracking, and notifications. This improves and simplifies therapy, alerts clinicians when to intervene, and overall improves patient care. Many medical institutions have begun to adopt integrated solutions for IoT-enabled medical devices to compensate for the shortage of doctors in distant places.
Synthetic Biosensors Market, By Product
- Wearable Synthetic Biosensors
- Non-wearable Synthetic Biosensors
Based on Product, the market is segmented into Wearable Synthetic Biosensors and Non-wearable Synthetic Biosensors. Wearable synthetic biosensors have drawn a lot of interest since they have the ability to alter current medical diagnostics and continuous health monitoring ideas. The goal of wearable biosensor applications is to convert centralized hospital care systems into individualized home medicine while lowering medical expenses and turnaround times.
Wearable synthetic biosensors are now revolutionizing society with a tsunami of innovation. Better clinical decisions are made possible by the availability of this real-time data, which leads to improved health outcomes and more effective utilization of the healthcare system. Synthetic biosensors that may be worn on the body can assist identify health issues early and prevent hospitalization. The market for wearable synthetic biosensors is predicted to increase more quickly as a result of such circumstances.
Synthetic Biosensors Market, By Technology
- Electrochemical Synthetic Biosensors
- Optical Synthetic Biosensors
- Piezoelectric Synthetic Biosensors
- Thermal Synthetic Biosensors
- Nanomechanical Synthetic Biosensors
Based on Technology, the market is segmented into Electrochemical Synthetic Biosensors, Optical Synthetic Biosensors, Piezoelectric Synthetic Biosensors, Thermal Synthetic Biosensors, and Nanomechanical Synthetic Biosensors. Electrochemical synthetic biosensors are being employed more often in non-medical applications including environmental monitoring and food and beverage quality control. Analyzing organic pesticides or inorganic compounds that interfere with the sensor’s biocatalytic capabilities can be done indirectly using electrochemical synthetic biosensors.
Synthetic Biosensors Market, By Application
- Point of Care (POC)
- Home Diagnostics
- Research Labs
- Environmental Monitoring
- Food & Beverages
- Biodefense
- Others
Based on Application, the market is segmented into Point of Care (POC), Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages, Biodefense, and Others. The home diagnostics category is expected to increase at the fastest rate over the projection period. The rising expansion of the healthcare business, the high acceptance rate of innovative diagnostic procedures, and the ease of utilizing medical equipment at home all contribute to the market’s growth. As a result, Synthetic Biosensors Market producers are increasing their manufacturing capacity. Furthermore, with the rising demand for wearables and the incidence of lifestyle-related disorders, the biosensor industry in the home diagnostics category has enormous potential.
Synthetic Biosensors Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
On the basis of Regional Analysis, The Global Synthetic Biosensors Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. In 2021, North America accounted for the largest market share in the Global Synthetic Biosensors Market due to the owing to the increased occurrence of life-threatening disorders. The progress of technology in the medical diagnostic business is one of the primary factors driving the North American biosensor market. North America’s medical institutes and pharmaceutical research and development organizations are driving market expansion in the area.
North America’s rising awareness of health issues, environmental risks, and food toxicity have increased the demand for synthetic biosensors. In North America, technological advances and innovations in diagnostic devices are boosting the Synthetic Biosensors Market. Throughout the projected period, Asia-Pacific is expected to have the largest market for synthetic biosensors. The market is rising in the Asia-Pacific region due to high population density and the incidence of lifestyle-related illnesses.
Key Players
The “Global Synthetic Biosensors Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Abbott, Bio-Rad Laboratories, Inc., Biosensors International Group, Ltd., Cytiva, Dexcom, Inc., DuPont, Lifescan IP Holdings, LLC, Masimo, Medtronic, and Roche.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
- In March 2022, Rockley and Medtronic will collaborate on the development of the recently announced Bioptx biomarker sensing technology. Companies collaborate to create regulated wearable gadgets for proactive and continuous monitoring.
- In January 2021, Roche and Sysmex announced a collaboration agreement to deliver hematological diagnostic solutions. The new collaboration will use IT technologies to improve healthcare decision-making and consumer experience. This long-running, effective collaboration is still expanding and offering hematological diagnostic breakthroughs to laboratories worldwide.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Synthetic Biosensors Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in global Synthetic Biosensors Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
Report Scope
Report Attributes | Details |
---|---|
Study Period | 2019-2030 |
Base Year | 2022 |
Forecast Period | 2023-2030 |
Historical Period | 2019-2021 |
Unit | Value (USD Billion) |
Key Companies Profiled | Abbott, Bio-Rad Laboratories, Inc., Biosensors International Group, Ltd., Cytiva, Dexcom, Inc., DuPont, Lifescan IP Holdings, LLC, Masimo, Medtronic, Roche. |
Segments Covered | By Type, By Product, By Technology, By Application, and By Geography. |
Customization scope | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |